BeStock  
Stocks › Medical Devices › BBNX

Beta Bionics BBNX

US equityMarket cap rank #3360Medical Devices
$13.36 +$0.04 (+0.30%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $13.36 0.00%
Open$13.05
Prev close$13.32
Day range$12.92 – $13.85
Volume960.3K
Market cap$726.34M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$35.51M+30.3% YoY
Operating profit-$26.61M-56.1% YoY
Net profit-$24.35M-71.4% YoY
Diluted EPS-$0.52-57.6% YoY
Free cash flow-$14.56M-45.5% YoY
Operating cash flow-$12.29M

Revenue, last 8 quarters

$20.4MDec '24$17.6MMar '25$23.2MJun '25$27.3MSep '25$32.1MDec '25$27.6MMar '26$32.0MJun '26$35.5MSep '26

Net profit, last 8 quarters

$-18.1MDec '24$-28.7MMar '25$-16.9MJun '25$-14.2MSep '25$-13.5MDec '25$-21.9MMar '26$-23.4MJun '26$-24.4MSep '26

Diluted EPS by quarter

-0.42Dec '24-0.93Mar '25-0.39Jun '25-0.33Sep '25-0.30Dec '25-0.49Mar '26-0.53Jun '26-0.52Sep '26

Free cash flow by quarter

$-14.8MDec '24$-20.3MMar '25$-15.4MJun '25$-10.0MSep '25$-10.5MDec '25$-25.2MMar '26$-15.7MJun '26$-14.6MSep '26

Annual revenue

$179.0KFY22$12.0MFY23$65.1MFY24$100.3MFY25

Profitability & balance sheet

Gross margin58.6%
Operating margin-72.7%
Net margin-65.3%
Return on equity-23.9%
Return on assets-21.5%
Return on invested capital-26.1%
Current ratio8.92
Liabilities / assets9.5%
Cash & investments$240.20M
Total debt$4.65M
Net cash (debt)$235.56M

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Single-use products$23.98M 67.5%
  • iLet$11.53M 32.5%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $35.51M $32.01M $27.63M $100.25M $32.12M
Total Operating Revenue $35.51M $32.01M $27.63M $100.25M $32.12M
Cost of Revenue $15.17M $13.11M $11.19M $44.71M $13.18M
Gross Profit $20.33M $18.90M $16.44M $55.54M $18.94M
Operating Expense $46.94M $44.48M $40.71M $127.22M $35.07M
Selling and Admin Expenses $34.97M $34.24M $30.35M $92.43M $24.94M
-Selling & Marketing Expense $25.12M $24.64M $20.74M $61.40M $16.33M
-General & Admin Expense $9.84M $9.60M $9.62M $31.03M $8.60M
Research & Development $11.98M $10.24M $10.36M $34.79M $10.13M
Operating Profit -$26.61M -$25.58M -$24.27M -$71.68M -$16.12M
Net Non-Operating Interest Income (Expense) $2.26M $2.18M $2.38M $10.93M $2.66M
Non-Operating Interest Income $2.26M $2.18M $2.38M $10.93M $2.66M
Other Income (Expense) -$2,000.00 -$2,000.00 – -$12.45M $0.00
Other Non-Operating Income (Expenses) -$2,000.00 -$2,000.00 – -$1,000.00 $0.00
Pretax Profit -$24.35M -$23.40M -$21.90M -$73.20M -$13.47M
Net Profit -$24.35M -$23.40M -$21.90M -$73.20M -$13.47M
Profit from Continuing Operations -$24.35M -$23.40M -$21.90M -$73.20M -$13.47M
Net Income to Parent Company -$24.35M -$23.40M -$21.90M -$73.20M -$13.47M
Net Income to Common Stockholders -$24.35M -$23.40M -$21.90M -$73.20M -$13.47M
Basic EPS -$0.52 -$0.53 -$0.49 -$1.81 -$0.30
Diluted EPS -$0.52 -$0.53 -$0.49 -$1.81 -$0.30
Gain on Sale of Security – – – -$12.45M $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $443.76M $292.39M $304.42M $328.74M $328.74M
Total Current Assets $292.95M $231.03M $247.99M $267.91M $267.91M
Cash and Cash Equivalents & Short-Term Investments $240.20M $180.49M $199.52M $219.13M $219.13M
-Cash and Cash Equivalents $81.55M $44.32M $30.21M $31.58M $31.58M
-Short Term Investments $158.65M $136.17M $169.31M $187.55M $187.55M
Receivables $23.75M $20.25M $18.14M $19.89M $19.89M
-Accounts Receivable $20.67M $18.05M $15.75M $17.12M $17.12M
-Accrued Interest Receivable $2.79M $1.91M $2.14M $2.51M $2.51M
-Taxes Receivable $293,000.00 $293,000.00 $251,000.00 $265,000.00 $265,000.00
Prepaid Assets $5.92M $6.28M $6.50M $7.06M $7.06M
Inventory $22.97M $23.92M $23.73M $21.72M $21.72M
Restricted Cash $100,000.00 $100,000.00 $100,000.00 $100,000.00 $100,000.00
Total Non-Current Assets $150.81M $61.35M $56.43M $60.84M $60.84M
Net PPE $17.17M $16.56M $16.39M $15.23M $15.23M
-Gross PPE $25.10M $23.61M $22.73M $20.98M $20.98M
-Accumulated Depreciation -$7.94M -$7.05M -$6.34M -$5.76M -$5.76M
Investments and Advances $133.44M $44.65M $39.87M $45.43M $45.43M
-Available for Sale Securities $133.44M $44.65M $39.87M $45.43M $45.43M
Other Non-Current Assets $212,000.00 $141,000.00 $181,000.00 $180,000.00 $180,000.00
Total Liabilities $42.38M $36.02M $33.17M $41.13M $41.13M
Total Current Liabilities $32.84M $26.02M $23.19M $30.92M $30.92M
Payables $4.68M $5.35M $2.32M $5.00M $5.00M
-Accounts Payable $4.68M $5.35M $2.32M $5.00M $5.00M
Current Accrued Expenses $7.98M $5.03M $6.11M $7.84M $7.84M
Short-Term Debt and Capital Lease Obligation $1.45M $1.59M $1.84M $1.94M $1.94M
-Current Capital Lease Obligation $1.45M $1.59M $1.84M $1.94M $1.94M
Current Provisions $1.76M $1.66M $1.61M $1.61M $1.61M
Current Deferred Liabilities $2.05M $1.88M $1.71M $1.56M $1.56M
Other Current Liabilities $1.27M $554,000.00 $623,000.00 $328,000.00 $328,000.00
Total Non-Current Liabilities $9.54M $10.00M $9.98M $10.21M $10.21M
Long Term Debt and Capital Lease Obligation $4.65M $4.92M $5.07M $5.37M $5.37M
-Long Term Capital Lease Obligation $4.65M $4.92M $5.07M $5.37M $5.37M
Non-Current Deferred Liabilities $3.48M $3.45M $3.35M $3.30M $3.30M
Other Non-Current Liabilities $1.41M $1.63M $1.56M $1.55M $1.55M
Total Equity $401.38M $256.37M $271.25M $287.61M $287.61M
Stockholders' Equity $401.38M $256.37M $271.25M $287.61M $287.61M
Capital Stock $5,000.00 $5,000.00 $5,000.00 $4,000.00 $4,000.00
-Common Stock $5,000.00 $5,000.00 $5,000.00 $4,000.00 $4,000.00
Additional Paid-In Capital $841.84M $671.99M $663.17M $657.14M $657.14M
Retained Earnings -$439.59M -$415.24M -$391.83M -$369.94M -$369.94M
Gains/Losses Not Affecting Retained Earnings -$877,000.00 -$390,000.00 -$96,000.00 $403,000.00 $403,000.00
Convertible preferred securities – $0.00 – $0.00 $0.00
Non-Current Deferred Assets – – – $0.00 $0.00
Derivative Product Liabilities – – – $0.00 $0.00
-Preferred Stock – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$12.29M -$14.62M -$23.83M -$50.93M -$8.63M
Net cash flow from continuing operations -$12.29M -$14.62M -$23.83M -$50.93M -$8.63M
Net Income from Continuing Operations -$24.35M -$23.40M -$21.90M -$73.20M -$13.47M
Depreciation & Depletion & Amortization $1.31M $1.12M $987,000.00 $2.88M $935,000.00
Change in Working Capital $4.26M $513,000.00 -$8.21M -$8.99M -$1.34M
-Change in Receivables -$2.65M -$2.32M $1.37M -$5.16M -$5.60M
-Change in Inventory $1.34M -$214,000.00 -$1.80M -$9.88M -$2.20M
-Change in Prepaid Assets -$530,000.00 $415,000.00 $951,000.00 -$5.81M -$413,000.00
-Change in Payables and Accrued Expense $6.62M $2.64M -$8.55M $9.52M $6.39M
-Change in Other Current Assets -$71,000.00 $40,000.00 -$1,000.00 -$30,000.00 $3,000.00
-Change in Other Current Liabilities -$629,000.00 -$329,000.00 -$380,000.00 $311,000.00 -$42,000.00
-Change In Other Working Capital $191,000.00 $280,000.00 $201,000.00 $2.06M $526,000.00
Net cash flow from investing -$114.08M $26.93M $21.84M -$162.81M $658,000.00
Net Cash Flow from Continuing Investing Activities -$114.08M $26.93M $21.84M -$162.81M $658,000.00
Net PPE Purchase and Sale -$2.28M -$1.04M -$1.38M -$5.30M -$1.90M
Net Investment Purchase and Sale -$111.81M $27.97M $23.22M -$157.51M $2.56M
Financing Cash Flow $163.60M $1.80M $623,000.00 $214.87M $1.06M
Net Cash Flow from Continuing Financing Activities $163.60M $1.80M $623,000.00 $214.87M $1.06M
Net Common Stock Issuance $161.80M $0.00 $0.00 $210.12M -$904,000.00
Proceeds from Stock Option Exercised $1.80M $1.80M $623,000.00 $4.76M $1.96M
Ending Cash Balance $81.65M $44.42M $30.31M $31.68M $31.68M
Net Change in Cash $37.23M $14.11M -$1.37M $1.14M -$6.91M
Beginning Cash Balance $44.42M $30.31M $31.68M $30.53M $38.59M
Free Cash Flow -$14.56M -$15.66M -$25.21M -$56.22M -$10.53M
Other Non-Cash Items – – $86,000.00 -$2.05M -$25,000.00
Gain/Loss from Continuing Operations – – – $12.48M $31,000.00
Net Preferred Stock Issuance – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on BBNX.

Sign in to join the discussion.

Scroll to Top